Global Peptic Ulcer Testing Market Research and Analysis

MARKET INSIGHTS

Global Peptic Ulcer Testing market is projected to witness a significant growth rate during the forecasted period 2017-2022. The growth of the market is backed by the increasing incidences of stomach cancer coupled with the changing lifestyle & food habits such as untimely meal patterns, excess consumption of fatty foods, chronic acidity and food poisoning. As per American Cancer Society, around 28,000 cases of stomach cancer is estimated to be diagnosed in the U.S. in 2017, up from 26,370 cases in 2016 and about 10,960 individuals are projected to die due to it. Such scenario has raised the need for faster as well as accurate diagnosis of peptic ulcer. The most commonly occurring stomach disease called peptic ulcer is primarily caused by sores and lesions owing to the excess secretion of the hydrochloric acid as well as pepsin enzyme from the histamine cells into the gastrointestinal tract. This disease generally occurs owing to the H. pylori (Helicobacter pylori) bacterium but can also be caused by long term usage of the non-steroidal anti-inflammatory drugs. Whereas in rare cases peptic ulcer can also occur due to presence of some specific illness or inheritance. However, only 10-15% of Helicobacter pylori positive cases develop peptic ulcers but up to 90% of all peptic ulcers occur owing to H. pylori.
In developing and underdeveloped countries, the prevalence of peptic ulcers is greater than in developed countries. This fact is further supported by the presence of high population within developing countries which is directly attributing towards the growth of the global peptic ulcer testing market.  The other key factors that are driving the growth of the global market are growing usage of rapid urease test for h. pylori detection and development of advanced & new testing techniques. However, medical reimbursement issues related to certain tests in some countries is currently hampering the growth of the global peptic ulcer testing market.

GEOGRAPHICAL INSIGHTS

Global Peptic Ulcer Testing market can be segmented geographically into Europe, North America, Asia Pacific and RoW. In 2016, Asia Pacific held the largest market in terms of rapid tests for H. pylori across the globe.  Whereas in terms of revenue generation, North America leads the global peptic ulcer testing market owing to the rise in number of people suffering from peptic ulcer. In the U.S., around 5 million individuals are affected by peptic ulcer at any given time. Peptic ulcer is an important cause of the morbidity as well as healthcare costs; estimates of expenditures related to hospitalization, work loss and outpatient care (excluding medication costs) totaled around $5.65 billion per year in the U.S. Whereas, Asia Pacific is expected to witness the highest growth rate during the forecasted period. In Asia Pacific region, the incidence of peptic ulcer disease is quite high as most countries within this region are developing or under-developed and have relatively poor sanitation & hygienic condition which results in rise to contracting H. pylori infections. As per WHO, peptic ulcer disease deaths reached 85,487 in India in 2014. The age adjusted death rate due to peptic ulcer disease in India is 9.12 per 100,000 people has ranked India #26 in the world. Such fact states the high incidence rate of peptic ulcer disease which has widened the scope for the growth of the peptic ulcer testing market in Asia Pacific.
The report includes detailed market overview, market determinants, company profiling, sector analysis, market segmentation, geographical analysis, patent analysis, strategic recommendations, key company analysis, gap analysis, key findings, market estimations, market insights, analyst insights and predictive analysis of the market.

Competitive Insights

The key players of Peptic Ulcer Testing market include Kibion AB, Beckman Coulter Inc., Biomerieux S.A., Otsuka America Pharmaceutical, Inc., Becton, Dickinson and Company, Quidel Corporation and Meridian Bioscience Inc. Merger & acquisition, product launch, strategic alliances and partnerships are the key strategies adopted by the market players. In 2015, Biomerieux launched bioNexia H. pylori Ag. test that allows the non-invasive detection of the helicobacter pylori antigen in human stool specimens. Launch of such advanced tests for the detection of h. pylori by the market players is expected to attribute significantly towards its KEY STRATEGY in the global market.

MARKET SEGMENTATION

Peptic Ulcer Testing Market by Diagnostic Tests
o Upper Endoscopy
o Gastrointestinal Endoscopy
Histology Tests
Immunostaining Techniques
Rapid Urease Tests
Gastritis assessment
Molecular Tests
Susceptibility Testing
Brush Cytology
Culture Tests
o Blood Tests
o ELISA Tests
o Urea Breath Test
o Stool Tests
o Other Tests
Peptic Ulcer Testing Market
o Hospitals
o Laboratories
o Others

OMR REPORT COVERS

• Comprehensive research methodology of global Peptic Ulcer Testing market
• In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global Peptic Ulcer Testing market
• Insights about market determinants which are stimulating the global Peptic Ulcer Testing market
• Detailed and extensive market segments with regional distribution of researched revenues
• Extensive profiles and recent developments of market players